# Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 Diabetes

> **NCT00571935** · PHASE4 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 61 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** insulin aspart
- **DRUG:** soluble human insulin

## Key facts

- **NCT ID:** NCT00571935
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2004-10
- **Final completion:** 2004-10
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2016-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00571935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00571935, "Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 Diabetes". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT00571935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*